Editas Medicine
EDIT
EDIT
264 hedge funds and large institutions have $591M invested in Editas Medicine in 2022 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 73 increasing their positions, 75 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.05% more ownership
Funds ownership: 69.17% → 70.22% (+1%)
3% less repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 75
Holders
264
Holding in Top 10
–
Calls
$23.8M
Puts
$18.6M
Top Buyers
| 1 | +$21.2M | |
| 2 | +$7.95M | |
| 3 | +$4.01M | |
| 4 |
Two Sigma Investments
New York
|
+$3.84M |
| 5 |
Man Group
London,
United Kingdom
|
+$3.79M |
Top Sellers
| 1 | -$18.7M | |
| 2 | -$12M | |
| 3 | -$5.35M | |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
-$4.81M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$4.81M |